Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein

Thumbnail
Date
2002-05-01
ICR Author
Enver, Tariq
Author
Tsuzuki, S
Enver, T
Type
Journal Article
Metadata
Show full item record
Abstract
Transcription factor GATA-2 Is Implicated in the survival and growth of multipotential progenitors. Here we report that the promyelocytic leukemia zinc finger (PLZF) protein can Interact with GATA-2 and can modify Its transactivation capacity. Fanconi anemia zinc finger (FAZF), a PLZF-homologous protein that has been variously described as ROG (repressor of GATA), and TZFP (testis zinc finger protein) also Interact with GATA-2. The zinc finger region of GATA-2 Is required for binding to PLZF and FAZF, but distinct Interfaces on the PLZF and FAZF molecules mediate the Interaction, suggesting that GATA-2 activity Is controlled by these 2 homologous proteins through distinct mechanisms. GATA-2 can also physically associate with the PLZF-RARalpha fusion protein generated by the t(11;17) chromosomal translocation associated with acute promyelocytic leukemia (APL). Functional experiments showed that this Interaction has the capacity to render GATA-dependent transcription responsive to treatment with ill combination of all-trans retinoic acid and the histone deacetylase Inhibitor trichostatin A (TSA). This combination of drugs has been shown to stimulate the terminal differentiation of leukemic t(11;17)-associated APL blasts, raising the possibility that GATA target genes may be Involved In the molecular pathogenesis of APL. (C) 2002 by The American Society of Hematology.
URI
https://repository.icr.ac.uk/handle/internal/2803
DOI
https://doi.org/10.1182/blood.V99.9.3404
Collections
  • Other ICR Research
Language
eng
License start date
2002-05-01
Citation
BLOOD, 2002, 99 pp. 3404 - 3410

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.